Yael Cohen, MD | Authors


Dr. Yael Cohen on VB111 as a Potential Treatment for Ovarian Cancer

December 28, 2015

Yael Cohen, MD, discusses VB111, a highly targeted anti-angiogenic agent. The treatment is currently going through a phase III trial for treating glioblastoma, phase I trial for thyroid cancer and phase II trial for ovarian cancer.